EFS of Posterior Leaflet Replacement to Reduce Mitral Regurgitation (United States)
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Polares Medical SA
- Study ID
- NCT07517588
- Status
- Recruiting
Conditions
- Mitral Regurgitation
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MR-ace Implant and Delivery System — DEVICEThis study device uses a transcatheter procedure through your leg veins to place the MRace implant and cover the posterior leaflet of your own mitral valve.
Study Details
The goal of this early feasibility clinical trial is to learn if the device MR-ace Implant and Delivery System works in patients with moderate or severe mitral valve regurgitation. It will also learn about the safety of the device MR-ace Implant and Delivery System. The main questions it aims to answer are: Does implanting the MR-ace device reduce the symptoms of mitral regurgitation? Does the device reduce the the leak through your mitral valve? Participants will: Be implanted with the device Visit the clinic for checkups and tests at 30 days, 6 months, 12 months, and 2, 3, 4 and 5 years following your procedure Complete a quality of life survey
Key Dates
- First listed
- Apr 8, 2026
- Start date
- Sep 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2032
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatmenttreatment with the study device
Primary Outcome Measure
Primary Safety Endpoint [ Time Frame: 30 days post procedure ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory Midtown | Atlanta | Georgia | 30308 | Adam Greenbaum, MD (PRINCIPAL_INVESTIGATOR) |
| Montefiore Medical Center | The Bronx | New York | 10467 | Mohamad Latib, MD (PRINCIPAL_INVESTIGATOR) |
| The Lindner Research Center at The Christ Hospital | Cincinnati | Ohio | 45219 | Santiago Garcia, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Atlanta, GA
Related Studies
- An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement SystemRecruiting · HighLife SAS · Tucson, Arizona
- The ENCIRCLE TrialRecruiting · Edwards Lifesciences · Huntsville, Alabama
- The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).Recruiting · Mayra Guerrero · Gilbert, Arizona
- Use of Phenylephrine for Assessment of Mitral Regurgitation SeverityPHASE1/PHASE2 · Recruiting · Montefiore Medical Center · New York, New York